Showing results (61-70 of 231) with videos related to
Sort By:
Pageof 24
Anticancer Research|July 1, 1997
Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cellsA G Zeimet, F A Offner, C Marth, et al.Cancer Research|July 1, 1985
Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expressionG Gastl, C Marth, E Leiter, et al.Journal of Interferon Research|April 1, 1987
Characterization of an interferon-resistant mutant of the human breast cancer cell line BT-20C Marth, G Gastl, J Zech, et al.Geburtshilfe Und Frauenheilkunde|August 1, 1992
[Magnetic resonance tomography in follow-up of hydatidiform mole]C Marth, W Judmaier, G Helweg, et al.The Journal of Urology|March 1, 1987
Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostatesG Bartsch, F Keen, G Daxenbichler, et al.British Journal of Cancer|January 1, 1997
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancerA G Zeimet, M Widschwendter, M Uhl-Steidl, et al.Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Immunostimulating protein 90K in ovarian carcinoma]A G Zeimet, C Marth, D Fuchs, et al.Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Relationship between quantity of silver stained nucleolar organizer region associated proteins (Ag-NORs) and growth rate suppression of breast cancer cell lines after interferon-gamma and 4-hydroxy-tamoxifen treatmentD Ofner, A Hittmair, C Marth, et al.Geburtshilfe Und Frauenheilkunde|June 1, 1995
[Endometriosis in tamoxifen therapy]L C Fuith, W PflanzlOncology|September 1, 1995
Prognostic value of CD44 splice variant expression in ovarian cancerM Uhl-Steidl, E Müller-Holzner, A G Zeimet, et al.Pageof 24